---
title: "CDH10"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Gene CDH10"
tags: ['GeneCDH10', 'CellAdhesion', 'Cancer', 'Mutation', 'Biomarker', 'Prognosis', 'DrugTargets', 'Metastasis']
---

# Gene CDH10

## General Information
- Function for gene: Cadherin-10 is a calcium-dependent cell-cell adhesion glycoprotein that supports cell-cell aggregation, tumor suppression, and regulates cell proliferation.
- External IDs for gene and genomic location, Aliases:
    - Gene ID: 1009
    - Genomic location: 5p14.1
    - Aliases: CDH9, T-Cadherin
- External sites:
    - HGNC: HGNC:1772
    - NCBI Entrez: 1009
    - Ensembl: ENSG00000168769
    - OMIM: 604555
    - UniProtKB/Swiss-Prot: O15708

## Mutation Information
- AA mutation list and mutation type with dbSNP ID:
    - p.Arg65Cys - Missense - rs137853327
    - p.Leu66Phe - Missense - rs138067973
    - p.Asp466His - Missense - rs555512437
- Somatic SNVs/InDels with dbSNP ID:
    - p.Val766Ile - Missense - rs1057518830
    - p.Asn163fs - Frameshift - rs1554329598
- Related disease: CDH10 mutations have been associated with different types of cancers, including thyroid, colon, and breast cancer.
- Treatment and prognosis: Treatment options and prognosis vary depending on the type and stage of cancer.
- Drug response: Further pharmacological studies are needed to explore potential drug targets for CDH10 mutations and related diseases.

## References
1. Chen et al. (2020). CDH10 inhibits metastasis, modulates cancer cell phenotype, and is associated with decreased mortality in advanced bladder cancer. DOI: 10.1038/s41391-020-0191-4
2. Cheng et al. (2019). CDH10 is a novel prognostic biomarker and correlated with immune infiltrates in gliomas. DOI: 10.1038/s41379-018-0177-2
3. OMIM: CDH10. URL: [Click](https://omim.org/entry/604555)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**